Afaxys Pharmaceuticals, a division of Afaxys, has introduced new generic, oral contraceptive Lyza (Norethindrone Tablets USP, 0.35mg) indicated for the prevention of pregnancy in women.
The generic contraceptive Lyza is available only to the public health sector, including family planning clinics, college and university health centers, community health centers, and city, county, state, and federal facilities in addition to authorized, non-retail prescribers.
The product is AB rated to Ortho Micronor and compares to the monophasic regimens Nora-BE, Errin, Heather, Jolivette, Camila and norethindrone, according to the company.
Afaxys Pharmaceuticals is a company with a mission to serve the public health sector with low-priced, readily available mission-critical products.
